The metabolic improvements associated with GLP-1 agonist use, including better glucose control and weight management, may indirectly contribute to improved brain health
It is usually recommended for smaller internal hemorrhoids
Awareness, not perfection
Therefore, further long-term studies with cardiovascular end points are warranted
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-nave patients with type 2 diabetes (SUSTAIN 4): A randomized, open-label, parallel-group, multicentre, multinational, phase 3a trial
The overall risk in the general population is 0.1%